Rolida, Ramel D.

HRN: 04-18-56  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/31/2025
09/07/2025
IV
600MG
Q8H
CELLULTIS
Checking Initial Appropriateness 
09/11/2025
CO-AMOXICLAV 625MG (TAB)
09/11/2025
09/17/2025
PO
625
TID
CEllulitis
Checking Initial Appropriateness 
09/11/2025
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
09/11/2025
09/17/2025
TOPICAL
Apply Thinly
BID
Cellulitis
Checking Initial Appropriateness 
09/12/2025
CLINDAMYCIN 300MG (CAP)
09/13/2025
09/15/2025
ORAL
600mg
Q8h
Cellulitis R Foot
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: